Regional surveillance of the evolution of Methicillin resistant Staphylococcus aureus (MRSA): What results for what teaching?;Surveillance régionale de l'évolution de Staphylococcus aureus résistant à la méticilline (SARM): Quels résultats pour quels enseignements?

Medecine et Maladies Infectieuses

Volumn 34, Issue 6, 2004, Pages 264-269

  Bertrand, X ^a   Claude, B ^a   Chantelat, P ^a   Paolini, M C ^a   Petitboulanger, N ^a   Julienne, C ^a   Bruand, L ^a   Huguenin, Y ^a   Mermet, F ^a   Talon, D ^a  

^a UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

Author keywords

pid miologie; Epidemiology; Methicillin resistant Staphylococcus aureus; Staphylococcus aureus r sistant la m ticilline

Indexed keywords

ANTIBIOTIC AGENT; GENTAMICIN; METICILLIN; OFLOXACIN; OXACILLIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TOBRAMYCIN;

ARTICLE; BACTEREMIA; BACTERIAL COLONIZATION; BACTERIAL INFECTION; CELL HETEROGENEITY; CONTROLLED STUDY; GLOBAL CHANGE; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; INFECTION PREVENTION; LONG TERM CARE; LUNG INFECTION; MAJOR CLINICAL STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MOLECULAR EVOLUTION; MORBIDITY; MULTIDRUG RESISTANCE; POSTMARKETING SURVEILLANCE; PUBLIC HOSPITAL; RISK FACTOR; TIME SERIES ANALYSIS;

CROSS INFECTION; FRANCE; HUMANS; METHICILLIN RESISTANCE; POPULATION SURVEILLANCE; RISK ASSESSMENT; STAPHYLOCOCCAL INFECTIONS;

EID: 3042530248     PISSN: 0399077X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.medmal.2004.04.005     Document Type: Article

References (17)

1. Comité Technique national des Infections Nosocomiales (CTIN). Maîtrise de la diffusion des bactéries multirésistantes aux antibiotiques. Recommandations pour les établissements de santé 1999;Ministère de l'Emploi et de la Solidarité, Secrétariat d'État à la Santé et à l'Action sociale
2. Albertini M.T., Benoit C., Berardi L., Berrouane Y., Boisivon A., Cahen P., et al. The Microbiology Surveillance Network of Northern France. Surveillance of methicillin-resistant Staphylococcus aureus (MRSA) and Enterobacteriaceae producing extended-spectrum beta-lactamase (ESBLE) in Northern France: a five-year multicentre incidence study. J Hosp Infect. 52:2002;107-113
3. Recommandations méthodologiques pour la surveillance de la résistance aux antibiotiques dans les laboratoires de microbiologie. ONERBA. http://www.onerba.org.
4. Members of the SFM Antibiogram comittee. Comité de l'antibiogramme de la Société française de microbiologie, Report 2003. Int J Antimicrob Agents. 21:2003;364-391
5. Chaix C., Durand-Zzaleski I., Alberti C., Brun-Buisson C. Control of endemic methicillin-resistant Staphylococcus aureus: a cost-benefit analysis in an intensive care unit. JAMA. 282:1999;1745-1751
6. Lucet J.C., Chevret S., Durand-Zaleski I., Chastang C., Regnier B. Multicenter Study Group. Prevalence and risk factors for carriage of methicillin-resistant Staphylococcus aureus at admission to the intensive care unit: results of a multicenter study. Arch Intern Med. 163:2003;181-188
7. Girou E., Pujade G., Legrand P., Cizeau F., Brun-Buisson C. Selective screening of carriers for control of methicillin-resistant Staphylococcus aureus (MRSA) in high-risk hospital areas with a high level of endemic MRSA. Clin Infect Dis. 27:1998;543-550
8. Talon D., Rouget C., Cailleaux V., Bailly P., Thouverez M., Barale F., et al. Nasal carriage of Staphylococcus aureus and cross-contamination in a surgical intensive-care unit: efficacy of mupirocin ointment. J Hosp Infect. 30:1995;39-49
9. Kauffman C.A., Bradley S.F., Terpenning M.S. Methicillin-resistant Staphylococcus aureus in long-term care facilities. Infect Control Hosp Epidemiol. 11:1990;600-603
10. O'Sullivan N.P., Keane C.T. Risk factors for colonization with methicillin-resistant Staphylococcus aureus among nursing home residents. J Hosp Infect. 45:2000;206-210
11. Talon D., Bertrand X. Methicillin-resistant Staphylococcus aureus in geriatric patients: usefulness of screening in a chronic care setting. Infect Control Hosp Epidemiol. 22:2001;505-509
12. Minary-Dohen P., Bailly P., Bertrand X., Talon D. Methicillin-resistant Staphylococcus aureus (MRSA) in rehabilitation and long-term-care facilities: what is the best strategy? BMC Geriatrics. 3:2003;5
13. Cosgrove S.E., Sakoulas G., Perencevich E.N., Schwaber M.J., Karchmer A.W., Carmeli Y. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteraemia: a meta-analysis. Clin Infect Dis. 36:2003;51-59
14. Campese C., Che D., Maine C., Decludt B. Les légionelloses déclarées en France en 2002. BEH. 32:2003;153-155
15. Bertrand X., Thouverez M., Talon D. Antibiotic susceptibility and genotypic characterization of methicillin-resistant Staphylococcus aureus strains in eastern France. J Hosp Infect. 46:2000;280-287
16. Talon D., Delière E., Bertrand X. Characterization of methicillin-resistant Staphylococcus aureus strains susceptible to tobramycin. Int J Antimicrob Agents. 20:2002;174-179
17. Thouverez M., Muller A., Hocquet D., Talon D., Bertrand X. Relationship between molecular epidemiology and antibiotic susceptibility of MRSA in a French University Hospital. J Med Microbiol. 52:2003;801-806